Results 111 to 120 of about 132,395 (346)

Ex Vivo Evaluation of Poly(Solketal Acrylate) Nanoparticles for Intravitreal Drug Delivery to the Posterior Eye Segment

Macromolecular Rapid Communications, EarlyView.
Nile Red‐loaded poly(solketal acrylate) nanoparticles enable fluorescence tracking and exhibit nontoxic profiles in retinal cells. Enhanced cellular uptake and deep retinal penetration after intravitreal injection highlight their excellent potential for targeted ocular drug delivery to the posterior segment of the eye.
Yasaman Pourdakheli Hamedani, José Hurst, Malte Ritter, Philipp Weingarten, Julia Skokowa, Sven Schnichels, Friederike Adams   +6 more
wiley   +1 more source

Perioperative visual loss with non-ocular surgery: Case report and review of literature

Indian Journal of Ophthalmology, 2014
Perioperative visual loss (POVL), a rare but devastating complication, has been reported after spine, cardiac, and head-neck surgeries.The various causes include ischemic optic neuropathy, central or branch retinal artery occlusion, and cortical ...
Nidhi Pandey, Ashok K Chandrakar, Mangi L Garg   +2 more
doaj   +1 more source

Economic evidence for licensed ready‐to‐administer intravenous products compared with standard vials and ampoules: a systematic review

Anaesthesia, EarlyView.
Summary Introduction Injectable medicines represent a significant proportion of the annual medicines expenditure of the NHS in England, totalling £7 billion ($9.4 billion, €8.0 billion) in 2023. This represents approximately 70% of hospital medicines spending and includes essential treatments delivered at the point of care, such as chemotherapy ...
Suzanne Al‐Rawi, Matthew Greening, Sue Ladds   +2 more
wiley   +1 more source

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy

BMJ Open Ophthalmology, 2019
Background/aims Preventing and treating proliferative vitreoretinopathy (PVR) remain a serious challenge for vitreoretinal surgeons. PVR is a devastating complication of retinal detachment that results in recurrent detachment and limits visual recovery ...
J. D. Benner, David Dao, John W. Butler, Kelli I Hamill   +3 more
semanticscholar   +1 more source

Interventions for submacular haemorrhage: A systematic review and network meta‐analysis of controversies—On behalf of the Spanish Vitreo‐Retinal Society (SERV)

Acta Ophthalmologica, EarlyView.
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate, Pablo Redruello‐Guerrero, Laura de Juan Hernández, Gregorio Benites‐Narcizo, Mario Rivera‐Izquierdo, José García‐Arumí, José Carlos Pastor Jimeno   +6 more
wiley   +1 more source

SD‐OCT‐based biomarkers in predicting treatment outcomes of macular oedema secondary to retinal vein occlusion treated with anti‐VEGF therapy

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate the role of spectral domain optical coherence tomography (SD‐OCT)‐based biomarkers in predicting treatment response of macular oedema (MO) secondary to retinal vein occlusion (RVO) to anti‐vascular endothelial growth factor (VEGF) therapy.
Ken K. Tsang, Vivian W. K. Hui, Christopher M. K. Pang, Ziqi Tang, Dawei Yang, Truong X. Nguyen, Shaheeda Mohamed, Timothy Y. Y. Lai, Carol Y. Cheung, Simon K. H. Szeto   +9 more
wiley   +1 more source

Competency‐based European training requirements for the specialty of ophthalmology. Recommendations from the UEMS section of ophthalmology and the European Board of Ophthalmology

Acta Ophthalmologica, EarlyView.
Abstract Purpose Ophthalmology encompasses comprehensive medical and surgical care for patients with diverse visual system disorders, significantly impacting eye health, vision, and quality of life. European ophthalmologists undergo specialized residency training to acquire necessary competencies, emphasizing theoretical knowledge, clinical and ...
Helena Prior Filipe, Rémi Yaïci, Renata Ivekovic, Denise Curtin, Rimvydas Asoklis, Huban Atilla, Elske Bak, Ana Pueyo‐Bestué, Michèle Beaconsfield, Catherine Creuzot‐Garcher, Barbara Cvenkel, Lisa Flanagan, Saskia Imhof, Tero Kivelä, Carina Koppen, Ewa Mrukwa‐Kominec, Anna Maino, Frédéric Mouriaux, Aurore Muselier, Sorcha Ni Dhubghaill, Karsten Paust, Siegfried Priglinger, Marcin Stopa, Brendan Strong, Felix Tanner, Marie‐José Tassignon, Paul Ursell, The ETR Subspecialties Working Group, Alain Bron, Nicolás Alejandre Alba, Ann Sofia Thomsen, Anthony Kawaja, Augusto Magalhães, Bahram Bodaghi, Béatrice Cochener, Dan Milea, Burkhard Dick, Filomena Ribeiro, Giorgio Porro, Gordana Sunaric Megevand, Hanne Olsen, Helgi Davio Bjornsson, Jelena Potic, Joao Barbosa Breda, Jorge Alió del Barrio, Kanav Khanna, Lauriana Solecki, Léa Dormegny, Léonard Sidhoum, Louis Arnould, Luis Abegão Pinto, Luis Fernandez Vega‐Cueto, Manon Grégoire, Marta Correia, Marta Karhanova, Marie Louise Rasmussen, Michael Stormly Hansen, Miguel Gonzalez‐Andrades, Miguel Lacerda Leitão, Mor Dickman, Neringa Jurkute, Nicole Eter, Oliver Niels Klefter, Rafael Martinez Costa, Santiago Ortiz, Sofia N Androudi, Tiago Monteiro, Thibaud Garcin, Vincent Borderie, Wagih Aclimandos, Tristan Bourcier   +70 more
wiley   +1 more source

Prefilled syringes for intravitreal drug delivery

Clinical Ophthalmology, 2019
Intravitreal injections of anti-vascular endothelial growth factor (VEGF) medications play an increasingly critical role in numerous retinal vascular diseases. Initially, anti-VEGF medications came in vials that had to be drawn up by the physician into a
Therese Sassalos, Y. Paulus
semanticscholar   +1 more source

Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem, Esra Inci, Martin Breimer, Sofia Töyrä Silfverswärd, Madeleine Zetterberg, Marita Andersson Grönlund   +5 more
wiley   +1 more source

Nanostructure-based platforms-current prospective in ophthalmic drug delivery

Indian Journal of Ophthalmology, 2014
The topically applied drugs as drops are washed off from the eye in very short period, resulting in low ocular bioavailability of drugs. Number of approaches have been attempted to increase the bioavailability and the duration of action of ocular drugs ...
Rakesh Kumar Sharma, Alaa Eldeen B Yassin   +1 more
doaj   +1 more source